20,99 €
inkl. MwSt.
Versandfertig in 6-10 Tagen
10 °P sammeln
Andere Kunden interessierten sich auch für
![Análise Gls para Identificação da Disfunção Ventricular Correcta]( "Análise Gls para Identificação da Disfunção Ventricular Correcta")
Análise Gls para Identificação da Disfunção Ventricular Correcta20,99 €![Right Ventricle & Pulmonary Hypertension]( "Right Ventricle & Pulmonary Hypertension")
Right Ventricle & Pulmonary Hypertension28,99 €![Apical Hypertrophic Cardiomyopathy]( "Apical Hypertrophic Cardiomyopathy")
Apical Hypertrophic Cardiomyopathy29,99 €![New insights in the assessment of right ventricular function]( "New insights in the assessment of right ventricular function")
New insights in the assessment of right ventricular function24,99 €![Morphometric Study Of The Ventricular System Of Brain]( "Morphometric Study Of The Ventricular System Of Brain")
Morphometric Study Of The Ventricular System Of Brain26,99 €![The efficacy of adrenaline in inducing ventricular tachycardia]( "The efficacy of adrenaline in inducing ventricular tachycardia")
The efficacy of adrenaline in inducing ventricular tachycardia28,99 €![Chemotherapy Analysis in Massive Transfusion Syndrome]( "Chemotherapy Analysis in Massive Transfusion Syndrome")
Chemotherapy Analysis in Massive Transfusion Syndrome17,99 €
Background: This study was designed to assess right ventricular (RV) systolic function in cancer patients. Methods and Results: Left ventricle (LV) and free-wall RV longitudinal strain were analysed prior and after 6 months of treatment (at 68 patients), using a vendor-independent software, together with left ventricular ejection fraction (LVEF), tricuspid annulus plane systolic excursion and RV fractional area change. Cancer therapy-related cardiac dysfunction was defined as a LVEF drop of >10% to <53%. Both LVEF fraction (59±7% vs. 55±8%, p<0.0001) and LV longitudinal strain (-19.7±2.5% vs. -17.1±2.6%, p<0.0001) were reduced.Cancer therapy-related cardiac dysfunction was detected in 20 patients (29%). In 15 out of these 20 patients (75%), a concomitant relative reduction in free-wall RV longitudinal strain magnitude by 17±7% was detected. A relative drop of RV longitudinal strain >17% had a sensitivity of 55% and a specificity of 70% to identify patients with cancer treatment. Conclusions: GLS analysis allows the identification of subclinical RV dysfunction appearing in the course of cancer treatment when conventional indices of RV dysfunction function are unaffected.